Comment are off
UT Health gets a $306,000 grant to study Ewing sarcoma
Dr. David Libich was quoted in an article by Kens 5 for his work on Ewing sarcoma.
September is Childhood Cancer Awareness Month. One of those cancers, Ewing sarcoma, is the second most common type of bone cancer in children with only 200 diagnosed each year in the U.S.
Thanks to a $306,000 grant from St. Baldrick’s, UT Health San Antonio is working to find a cure for this rare disease.
David Libich, an assistant professor at UT Health San Antonio said, “In many pediatric cancers, there’s usually a singular, or maybe one or two mutational events that drive the cell to become cancerous.”
Dr. Libich has been studying Ewing sarcoma for the past two years. He says the grant from St. Baldrick’s is a big deal. He added, “There’s not a lot of funding dedicated to pediatric cancers, mostly because they are extremely rare relative to the occurrences of adult cancers.”
